acetyl l-carnitine and myasthenia gravis Gravis: Causes, Risk Factors, Diagnosis, Treatment Current/Future Research Complementing Treatments for Myasthenia Gravis
Description
doi: 10.7717/peerj.13992 5 CalcaterraVVerduciECenaHMagenesVCTodiscoCFTenutaEet al
[DOI] [PubMed] [Google Scholar] 251.Beaudin A.E., Stover P.J
Consistently, overexpression of ODC increases mitochondrial 2-KG efflux, thereby reducing cell proliferation and colony formation [100,101]
multiple injections per day or spaced dosing to mimic natural GH pulses)
05186-2/asset/5421a2f6-be45-46ba-b83d-abba09eb7c93/main.assets/gr1_lrg.jpg)
